The true fraction of repeating fast radio bursts revealed through CHIME source count evolution

Fast Radio Bursts (FRBs) are classified into repeaters and non-repeaters, with only a few percent of the observed FRB population from the Canadian Hydrogen Intensity Mapping Experiment (CHIME) confirmed as repeaters. However, this figure represents only a lower limit due to the observational biases, and the true fraction of repeaters remains unknown. Correcting for these biases uncovers a notable decline in apparently non-repeating FRB detection rate as the CHIME operational time increases. This finding suggests that a significant portion of apparently non-repeating FRBs could in fact exhibit repetition when observed over more extended periods. A simple population model infers that the true repeater fraction likely exceeds 50% with 99% confidence, a figure substantially larger than the observed face value, even consistent with 100%. This greater prevalence of repeaters had previously gone unnoticed due to their very low repetition rates ($\sim$10$^{-3.5}$ hr$^{-1}$ on average). Hence, theoretical FRB models must incorporate these low-rate repeaters. Furthermore, our results indicate a significantly higher repeater volume number density, potentially exceeding observed values by up to 10$^4$ times, which in turn impacts comparisons with potential FRB progenitors.Comment: 7 pages, 7 figures, submitted to MNRA

The molecular gas kinematics in the host galaxy of non-repeating FRB 180924B

Fast radio bursts (FRBs) are millisecond-duration transients with large dispersion measures. The origin of FRBs is still mysterious. One of the methods to comprehend FRB origin is to probe the physical environments of FRB host galaxies. Mapping molecular-gas kinematics in FRB host galaxies is critical because it results in star formation that is likely connected to the birth of FRB progenitors. However, most previous works of FRB host galaxies have focused on its stellar component. Therefore, we, for the first time, report the molecular gas kinematics in the host galaxy of the non-repeating FRB 180924B at $z= 0.3216$. Two velocity components of the CO (3-2) emission line are detected in its host galaxy with the Atacama Large Millimeter/submillimeter Array (ALMA): the peak of one component ($-155.40$ km s$^{-1}$) is near the centre of the host galaxy, and another ($-7.76$ km s$^{-1}$) is near the FRB position. The CO (3-2) spectrum shows asymmetric profiles with A$_{\rm peak}$ $=2.03\pm 0.39$, where A$_{\rm peak}$ is the peak flux density ratio between the two velocity components. The CO (3-2) velocity map also indicates an asymmetric velocity gradient from $-180$ km s$^{-1}$ to 8 km s$^{-1}$. These results indicate a disturbed kinetic structure of molecular gas in the host galaxy. Such disturbed kinetic structures are reported for repeating FRB host galaxies using HI emission lines in previous works. Our finding indicates that non-repeating and repeating FRBs could commonly appear in disturbed kinetic environments, suggesting a possible link between the gas kinematics and FRB progenitors.Comment: 5 pages, 4 figures, Accepted for publication in MNRAS, https://www.youtube.com/watch?v=CldxLE7Pdwk&t=1

Galaxy source counts at 7.7 μ\mum, 10 μ\mum and 15 μ\mum with the James Webb Space Telescope

We present mid-infrared galaxy number counts based on the Early Release Observations obtained by the James Webb Space Telescope (JWST) at 7.7-, 10- and 15-$\mu$m (F770W, F1000W and F1500W, respectively) bands of the Mid-Infrared Instrument (MIRI). Due to the superior sensitivity of JWST, the 80 percent completeness limits reach 0.32, 0.79 and 2.0 $\mu$Jy in F770W, F1000W and F1500W filters, respectively, i.e., $\sim$100 times deeper than previous space infrared telescopes such as Spitzer or AKARI. The number counts reach much deeper than the broad bump around $0.05\sim0.5$ mJy due to polycyclic aromatic hydrocarbon (PAH) emissions. An extrapolation towards fainter flux from the evolutionary models in the literature agrees amazingly well with the new data, where the extrapolated faint-end of infrared luminosity functions combined with the cosmic star-formation history to higher redshifts can reproduce the deeper number counts by JWST. Our understanding of the faint infrared sources has been confirmed by the observed data due to the superb sensitivity of JWST.Comment: 6 pages, 8 figures. Accepted for publication in MNRA

Polycyclic aromatic hydrocarbon (PAH) luminous galaxies in JWST CEERS data

It has been an unanswered question how many dusty galaxies have been undetected from the state-of-the-art observational surveys. JWST enables us to detect faint IR galaxies that have prominent polycyclic aromatic hydrocarbon (PAH) features in the mid-IR wavelengths. PAH is a valuable tracer of star formation and dust properties in the mid-infrared wavelength. The JWST Cosmic Evolution Early Release Science (CEERS) fields provide us with wavelength coverage from 7.7 to 21 $\mu$m using six photometric bands of the mid-infrared instrument (MIRI). We have identified galaxies dominated by mid-IR emission from PAHs, termed PAH galaxies. From our multi-band photometry catalogue, we selected ten PAH galaxies displaying high flux ratios of $\log(S_{15}/S_{10}) > 0.8$. The SED fitting analysis indicates that these galaxies are star-forming galaxies with total IR luminosities of $10^{10}$ $\sim$ $10^{11.5}$ $L_{\odot}$ at z $\sim 1$. The morphology of PAH galaxies does not show any clear signatures of major merging or interaction within the MIRI resolution. The majority of them are on the star-formation main sequence at $z \sim 1$. Our result demonstrates that JWST can detect PAH emissions from normal star-forming galaxies at $z \sim 1$, in addition to ultra-luminous infrared galaxies (ULIRGs) or luminous infrared galaxies (LIRGs).Comment: 12 pages, 20 figures, 4 tables. Accepted by MNRAS. A summary video is at https://www.youtube.com/watch?v=UtPaVTFM4f8&ab_channel=NTHUCosmolog

Trypsin-induced proteome alteration during cell subculture in mammalian cells

<p>Abstract</p> <p>Background</p> <p>It is essential to subculture the cells once cultured cells reach confluence. For this, trypsin is frequently applied to dissociate adhesive cells from the substratum. However, due to the proteolytic activity of trypsin, cell surface proteins are often cleaved, which leads to dysregulation of the cell functions.</p> <p>Methods</p> <p>In this study, a triplicate 2D-DIGE strategy has been performed to monitor trypsin-induced proteome alterations. The differentially expressed spots were identified by MALDI-TOF MS and validated by immunoblotting.</p> <p>Results</p> <p>36 proteins are found to be differentially expressed in cells treated with trypsin, and proteins that are known to regulate cell metabolism, growth regulation, mitochondrial electron transportation and cell adhesion are down-regulated and proteins that regulate cell apoptosis are up-regulated after trypsin treatment. Further study shows that bcl-2 is down-regulated, p53 and p21 are both up-regulated after trypsinization.</p> <p>Conclusions</p> <p>In summary, this is the first report that uses the proteomic approach to thoroughly study trypsin-induced cell physiological changes and provides researchers in carrying out their experimental design.</p

Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice

BACKGROUND: Pten functionally acts as a tumor suppressor gene. Lately, tissue-specific ablation of Pten gene in mice has elucidated the role of Pten in different tumor progression models. However, a temporally controlled Pten loss in all adult tissues to examine susceptibility of various tissues to Pten-deficient tumorigenesis has not been addressed yet. Our goal was to explore the genesis of Pten-deficient malignancies in multiple tissue lineages of the adult mouse. METHODS AND FINDINGS: We utilized an inducible Cre/loxP system to delete Pten exon 5 in the systemic organs of ROSA26 (R26)-CreER(T);Pten(fx/fx) mice. On reaching 45 weeks 4OHT-induced Pten loss, we found that the R26-CreER(T);Pten(fx/fx) mice developed a variety of malignancies. Overall tumor mean latency was 17 weeks in the Pten-deficient mice. Interestingly, mutant females developed malignancies more quickly at 10 approximately 11 weeks compared with a tumor latency of 21 weeks for mutant males. Lymphoma incidence (76.9% in females; 40.0% in males) was higher than the other malignancies found in the mutant mice. Mutant males developed prostate (20.0%), intestinal cancer (35.0%) and squamous cell carcinoma (10.0%), whereas the mutant females developed squamous cell carcinoma (15.4%) and endometrial cancer (46.1%) in addition to lymphomas. Furthermore, we tested the pharmacological inhibition of the PTEN downstream effectors using LY294002 on Pten-deficient prostate hyperplasia. Our data revealed that, indeed, the prostate hyperplasia resulting from the induced Pten loss was significantly suppressed by LY294002 (p = 0.007). CONCLUSIONS: Through monitoring a variety of Pten-deficient tumor formation, our results revealed that the lymphoid lineages and the epithelium of the prostate, endometrium, intestine and epidermis are highly susceptible to tumorigenesis after the Pten gene is excised. Therefore, this R26-CreER(T); Pten(fx/fx) mouse model may provide an entry point for understanding the role of Pten in the tumorigenesis of different organs and extend the search for potential therapeutic approaches to prevent Pten-deficient malignancies

Women with endometriosis have higher comorbidities: Analysis of domestic data in Taiwan

AbstractEndometriosis, defined by the presence of viable extrauterine endometrial glands and stroma, can grow or bleed cyclically, and possesses characteristics including a destructive, invasive, and metastatic nature. Since endometriosis may result in pelvic inflammation, adhesion, chronic pain, and infertility, and can progress to biologically malignant tumors, it is a long-term major health issue in women of reproductive age. In this review, we analyze the Taiwan domestic research addressing associations between endometriosis and other diseases. Concerning malignant tumors, we identified four studies on the links between endometriosis and ovarian cancer, one on breast cancer, two on endometrial cancer, one on colorectal cancer, and one on other malignancies, as well as one on associations between endometriosis and irritable bowel syndrome, one on links with migraine headache, three on links with pelvic inflammatory diseases, four on links with infertility, four on links with obesity, four on links with chronic liver disease, four on links with rheumatoid arthritis, four on links with chronic renal disease, five on links with diabetes mellitus, and five on links with cardiovascular diseases (hypertension, hyperlipidemia, etc.). The data available to date support that women with endometriosis might be at risk of some chronic illnesses and certain malignancies, although we consider the evidence for some comorbidities to be of low quality, for example, the association between colon cancer and adenomyosis/endometriosis. We still believe that the risk of comorbidity might be higher in women with endometriosis than that we supposed before. More research is needed to determine whether women with endometriosis are really at risk of these comorbidities

Dehydrocostuslactone Suppresses Angiogenesis In Vitro and In Vivo through Inhibition of Akt/GSK-3β and mTOR Signaling Pathways

The traditional Chinese medicine component dehydrocostuslactone (DHC) isolated from Saussurea costus (Falc.) Lipschitz, has been shown to have anti-cancer activity. Angiogenesis is an essential process in the growth and progression of cancer. In this study, we demonstrated, for the first time, the anti-angiogenic mechanism of action of DHC to be via the induction of cell cycle progression at the G0/G1 phase due to abrogation of the Akt/glycogen synthase kinase-3β (GSK-3β)/cyclin D1 and mTOR signaling pathway. First, we demonstrated that DHC has an anti-angiogenic effect in the matrigel-plug nude mice model and an inhibitory effect on human umbilical vein endothelial cell (HUVEC) proliferation and capillary-like tube formation in vitro. DHC caused G0/G1 cell cycle arrest, which was associated with the down-regulation of cyclin D1 expression, leading to the suppression of retinoblastoma protein phosphorylation and subsequent inhibition of cyclin A and cdk2 expression. With respect to the molecular mechanisms underlying the DHC-induced cyclin D1 down-regulation, this study demonstrated that DHC significantly inhibits Akt expression, resulting in the suppression of GSK-3β phosphorylation and mTOR expression. These effects are capable of regulating cyclin D1 degradation, but they were significantly reversed by constitutively active myristoylated (myr)-Akt. Furthermore, the abrogation of tube formation induced by DHC was also reversed by overexpression of Akt. And the co-treatment with LiCl and DHC significantly reversed the growth inhibition induced by DHC. Taken together, our study has identified Akt/GSK-3β and mTOR as important targets of DHC and has thus highlighted its potential application in angiogenesis-related diseases, such as cancer

Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20( S )-Sulfonylamidine Derivatives of Camptothecin as Potent Antitumor Agents

Twelve novel 20-sulfonylamidine derivatives (9a–9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate

Large expert-curated database for benchmarking document similarity detection in biomedical literature search

Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe